Cardiovascular Genetic Epidemiology in the Genome-Wide Era: From Association Discovery to Mechanistic Dissection and Clinical Translation
Cardiovascular Drugs and Therapy · 2026-12 · 40 (6) · 2341-2364
DOI: 10.1007/s10557-026-07902-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 19.06.2026. Verfasst von Zhaoqi Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Cardiovascular Diseases, Translational Research, Biomedical, Molecular Epidemiology. Die Arbeit nennt 159 Literaturangaben. Gefördert von: 2025 Scientific and Technological Innovation Project for Graduate Students of China Academy of Chinese Medical Sciences, Academic Inheritance and Communication Project of China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Despite major advances in prevention and treatment, cardiovascular disease remains a leading cause of death and disability worldwide. Cardiovascular genetic epidemiology has moved from family-based and candidate-gene studies to a genome-wide discipline supported by genome-wide association studies (GWAS), population-scale biobanks, whole-genome sequencing, and multi-omics resources. This narrative review examines how the field is shifting from locus discovery toward a continuous but still incomplete evidence chain that links variants to genes, cellular context, causal pathways, functional validation, and clinical use. We emphasize a central tension: cardiovascular genetics has been exceptionally successful at discovering associations, but robust mechanistic resolution and implementation-ready clinical translation remain uneven across diseases, populations, and use cases. We synthesize progress in coronary artery disease, blood pressure traits, atrial fibrillation, stroke, heart failure, inherited cardiovascular disorders, and intermediate phenotypes, and we distinguish established applications from promising but still emerging approaches such as polygenic risk scores, spatial omics, EHR-linked implementation, and genetically informed target prioritization. We also highlight persistent bottlenecks, including ancestry imbalance, noncoding locus interpretation, limited functional validation, imperfect polygenic score portability, data-governance constraints, and the need for privacy-preserving analytical frameworks. Overall, the next phase of cardiovascular genetic epidemiology will depend less on the mere accumulation of loci and more on rigorous evidence triangulation, context-specific functional testing, ancestry equity, and feasible clinical implementation pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. liuzhiming2018@gamyy.cn.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. liuruxiu1@163.com.
Förderung
- 2025 Scientific and Technological Innovation Project for Graduate Students of China Academy of Chinese Medical Sciences
- Academic Inheritance and Communication Project of China Academy of Chinese Medical Sciences
Zitieren
APA
Yan, Z., Pu, X., Cai, Y., Wu, Q., Zhang, X., Chang, X., Liu, J., Wang, Y., Liu, Z., & Liu, R. (2026). Cardiovascular Genetic Epidemiology in the Genome-Wide Era: From Association Discovery to Mechanistic Dissection and Clinical Translation. Cardiovascular Drugs and Therapy, 40(6), 2341-2364. https://doi.org/10.1007/s10557-026-07902-6
Vancouver
Yan Z, Pu X, Cai Y, Wu Q, Zhang X, Chang X, et al. Cardiovascular Genetic Epidemiology in the Genome-Wide Era: From Association Discovery to Mechanistic Dissection and Clinical Translation. Cardiovascular Drugs and Therapy. 2026;40(6):2341-2364. doi:10.1007/s10557-026-07902-6
BibTeX
@article{Yan2026,
author = {Yan, Zhaoqi and Pu, Xiangyi and Cai, Yongyuan and Wu, Qiaomin and Zhang, Xinai and Chang, Xing and Liu, Jinfeng and Wang, Yanli and Liu, Zhiming and Liu, Ruxiu},
title = {Cardiovascular Genetic Epidemiology in the Genome-Wide Era: From Association Discovery to Mechanistic Dissection and Clinical Translation},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
volume = {40},
number = {6},
pages = {2341--2364},
doi = {10.1007/s10557-026-07902-6}
}
EUVIMED